- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bile Duct Cancer in Mexico
Total 1261 results
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, United Kingdom, Germany, Austria, India
-
Merck KGaA, Darmstadt, GermanyCompletedNon Small Cell Lung Cancer (NSCLC)Sweden, Australia, Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Turkey, United Kingdom, Germany, Poland, Ukraine, Argentina, Austria, Hungary, Netherlands, Slovakia, Taiwan, Chil... and more
-
Hoffmann-La RocheCompletedCervical CancerArgentina, Panama, Portugal, Spain, Turkey, Brazil, Colombia, Romania, Italy, Poland, France, Bulgaria, South Africa, Mexico, Russian Federation, Serbia, Costa Rica, Greece
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingGastric Cancer | Esophageal Adenocarcinoma | Gastroesophageal Junction CancerUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Czechia, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Si... and more
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerCanada, Italy, Hungary, Taiwan, Turkey, Belgium, Germany, Spain, United States, Singapore, Australia, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, France, Russian Federation, Argentina, Brazil, Malaysia, Portugal, Col... and more
-
Bristol-Myers SquibbWithdrawnMelanoma | Renal Cell Carcinoma | Lung CancerUnited States
-
Regeneron PharmaceuticalsRecruitingAdvanced Non-Small Cell Lung CancerKorea, Republic of, United States, Israel, Malaysia, Australia, Georgia, Turkey, Canada
-
Eli Lilly and CompanyCompletedAdvanced Non-Small Cell Lung CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingOvarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Stage III Fallopian Tube Cancer AJCC v7 | Stage III Primary Peritoneal Cancer... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER2/Neu Over-expressing Locally Advanced Breast CancerChina, United States, France, Hungary, Turkey, Japan, Germany, Singapore, Italy, Poland, Spain, United Kingdom, Thailand, Israel, Australia, Belgium, Greece, Argentina, Czech Republic, Mexico, Slovakia
-
Momenta Pharmaceuticals, Inc.TerminatedMetastatic Pancreatic CancerUnited States, Canada
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingAdvanced CancerSpain, Argentina, United States, Korea, Republic of, Taiwan, Belgium, Romania, Germany, United Kingdom, Australia, Brazil, Canada, China, Czechia, Denmark, France, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Mexico, Netherlands, ... and more
-
PfizerRecruitingAdvanced or Metastatic Breast CancerUnited States, Taiwan, Canada, Japan, China, Korea, Republic of, Israel, Argentina, Mexico, Australia, Brazil, United Kingdom, India
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Germany, Spain, Taiwan, Australia, Canada, Italy
-
Ambrx, Inc.RecruitingHER2 Positive Metastatic Breast CancerUnited States, Korea, Republic of, France, Australia
-
Tolmar Inc.RecruitingBreast CancerUnited States, Mexico, Brazil, Canada, Puerto Rico, Argentina
-
GOG FoundationNovartis PharmaceuticalsActive, not recruitingAdvanced, Persistent, or Recurrent Endometrial CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingMelanoma | Renal Cell Carcinoma | NSCLC | SCLC | Breast Carcinoma | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Brain Metastases, AdultUnited States
-
BayerActive, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
Alliance Foundation Trials, LLC.Pfizer; Syneos Health; UNICANCER; German Breast Group; SOLTI Breast Cancer Research... and other collaboratorsActive, not recruitingHER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
Innocrin PharmaceuticalProstate Cancer Foundation; Prostate Cancer Clinical Trials ConsortiumCompleted
-
OBI Pharma, IncRecruitingTriple Negative Breast CancerChina, Taiwan, United States, Korea, Republic of, Australia, Brazil, Hong Kong, Mexico, Russian Federation, South Africa, Ukraine, Peru, Poland
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Urethral CancerUnited States
-
Novartis PharmaceuticalsCompletedCancerGermany, Greece, Italy, Poland, Spain, Bulgaria, France, Serbia, Mexico, Chile
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, South Africa, Korea, Republic of, Poland, Taiwan, Singapore, Japan, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung CancerSpain, Argentina, China, France, Turkey, Brazil, Korea, Republic of, Mexico, Chile, Guatemala, Thailand, Costa Rica, United Kingdom, New Zealand, Hungary, Latvia, Russian Federation, Peru, South Africa, Ukraine, Italy, Greece, Poland
-
Pfizer's Upjohn has merged with Mylan to form Viatris...TerminatedCancer | Bone Neoplasms | Pain, IntractableItaly, Spain, United States, Canada, France, Hungary, Poland, Sweden, Taiwan, Korea, Republic of, Philippines, Peru, Venezuela, Finland, Czechia, Egypt, Mexico, Russian Federation, Thailand
-
Hoffmann-La RocheGenentech, Inc.CompletedBreast CancerItaly, Spain, Sweden, China, Hong Kong, Canada, South Africa, Ukraine, United States, United Kingdom, Russian Federation, Taiwan, Australia, Mexico, Turkey, Israel, Poland, Bulgaria, Germany, France, Netherlands, Norway, India, Hungary, Brazi... and more
-
ImmunityBio, Inc.RecruitingNon-muscle Invasive Bladder CancerUnited States
-
Nymox CorporationCompletedProstate CancerUnited States
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more
-
Genentech, Inc.23andMe, Inc.CompletedBreast Cancer | Glioblastoma | Colorectal Cancer | Non-Small Cell Lung Cancer | Renal Cell CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Canada, Denmark, France, Italy, Poland, Portugal, Spain, United Kingdom, Norway, Germany, Mexico
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, Canada
-
Seagen Inc.Merck Sharp & Dohme LLCTerminatedMelanoma | Lymphoma | Lymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Carcinoma, Non-Small-Cell Lung | Carcinoma, Squamous Cell | Neoplasm Metastasis | Hodgkin Disease | Pancreatic Adenocarcinoma | Non-Small Cell Lung Cancer | Squamous Cell Carcinoma of the Head... and other conditionsUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
AmgenCompletedMetastatic Colorectal Cancer | Colorectal Cancer | Rectal Cancer | Colon CancerUnited States, Belgium, Canada, Italy, Germany, Spain
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada, Netherlands, United Kingdom, Belgium, Germany, Hungary, Czech Republic, Finland, Mexico, Poland, Romania, Russian Federation, Ukraine
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
Threshold PharmaceuticalsPPDCompletedPancreatic CancerUnited States, Brazil, Ukraine, India, Russian Federation, Romania, Hungary, Mexico, Argentina, Bulgaria, Czech Republic
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Carcinoma | Stage IIIA Uterine Corpus Cancer | Stage IIIB Uterine Corpus Cancer | Stage IVA Uterine Corpus Cancer | Stage IVB Uterine Corpus Cancer | Stage IIIC1 Uterine Corpus Cancer | Stage IIIC2 Uterine Corpus CancerUnited States
-
Tragara Pharmaceuticals, Inc.CompletedPancreatic Cancer | Metastatic Pancreatic CancerUnited States
-
Neovii BiotechFresenius Biotech North AmericaCompletedOvarian CancerUnited States
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
GlaxoSmithKlineActive, not recruitingNeoplasms, BreastUnited States, Argentina, France, Netherlands, Finland, Spain, Israel, Poland, Romania, Mexico, Canada, Belgium, Germany, Hungary, Portugal, United Kingdom, Ireland, Australia, Italy, Brazil, Japan, Austria, Russian Federation, South... and more
-
Genentech, Inc.UnknownMetastatic Breast CancerAustralia, Spain, Greece, Mexico, Russian Federation, United States, Singapore, Canada, Peru, Taiwan, Korea, Republic of, Philippines, Netherlands, United Kingdom, France, Brazil, Ukraine, Sweden, Guatemala, Panama, Norway, Uruguay
-
Gilead SciencesMerck KGaA, Darmstadt, GermanyRecruitingMetastatic Urothelial CancerItaly, United States, Korea, Republic of, Spain, Greece, France, Germany, United Kingdom, Turkey
-
Astellas Pharma Global Development, Inc.RecruitingProstate Cancer | mCRPC | mCSPCUnited States
-
AstraZenecaActive, not recruitingNon-small Cell Lung Cancer NSCLCUnited Kingdom, Belgium, United States, Korea, Republic of, Hungary, Japan, Russian Federation, Poland, Ukraine, India, Mexico, Netherlands